Drug Shortage Report for ACT EXEMESTANE

Last updated on 2022-09-23 History
Report ID 170011
Drug Identification Number 02390183
Brand name ACT EXEMESTANE
Common or Proper name ACT-EXEMESTANE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) EXEMESTANE
Strength(s) 25MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30
ATC code L02BG
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-22
Estimated end date 2022-12-20
Actual end date
Shortage status Actual shortage
Updated date 2022-09-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-09-23 English Compare
v2 2022-09-22 French Compare
v1 2022-09-22 English Compare

Showing 1 to 3 of 3